LONG‑TERM INFUSION OF DOCETAXEL (TAXOTERE) DURING 2ND LINE POLYCHEMOTHERAPY IN PATIENTS WITH PROGRESSIVE SOLID TUMORS

Kovtun V.A., Gayevoy K.V., Sevidov V.V.

Methodology and results (acceptability, unbiased response) of docetaxel application (Texotere «Sanofi-Aventis Group») by long-term infusion during 2nd line polychemotherapy in patients with progressive solid tumors were introduced.